[go: up one dir, main page]

AR082155A1 - Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido - Google Patents

Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido

Info

Publication number
AR082155A1
AR082155A1 ARP110102499A ARP110102499A AR082155A1 AR 082155 A1 AR082155 A1 AR 082155A1 AR P110102499 A ARP110102499 A AR P110102499A AR P110102499 A ARP110102499 A AR P110102499A AR 082155 A1 AR082155 A1 AR 082155A1
Authority
AR
Argentina
Prior art keywords
antiseptic
iodine content
disinfectant formulation
reduced iodine
disinfectant
Prior art date
Application number
ARP110102499A
Other languages
English (en)
Original Assignee
Egis Gyogyszergyar Nyilvanosan Mukoedo Reszvenytarsasag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan Mukoedo Reszvenytarsasag filed Critical Egis Gyogyszergyar Nyilvanosan Mukoedo Reszvenytarsasag
Publication of AR082155A1 publication Critical patent/AR082155A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/12—Iodine, e.g. iodophors; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cleaning By Liquid Or Steam (AREA)

Abstract

Reivindicación 1: Uso de la solución de yodo elemental preparada con un vehículo tipo siloxano orgánico y de modo opcional que contiene excipientes adicionales o ingredientes farmacéuticamente activos como un desinfectante o como un agente antiséptico.
ARP110102499A 2010-07-12 2011-07-12 Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido AR082155A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1000362A HUP1000362A2 (en) 2010-07-12 2010-07-12 Antiseptic and disinfecting compositions having reduced iodine content

Publications (1)

Publication Number Publication Date
AR082155A1 true AR082155A1 (es) 2012-11-14

Family

ID=89989820

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110102499A AR082155A1 (es) 2010-07-12 2011-07-12 Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido

Country Status (11)

Country Link
EP (1) EP2592935A2 (es)
AR (1) AR082155A1 (es)
BR (1) BR112013000690A2 (es)
EA (1) EA022847B1 (es)
GE (1) GEP20156236B (es)
HK (1) HK1150373A2 (es)
HU (1) HUP1000362A2 (es)
TW (1) TW201216859A (es)
UA (1) UA109144C2 (es)
UY (1) UY33502A (es)
WO (1) WO2012007776A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012150891A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Composition for administration of a pharmacologically or cosmetically active agent onto a surface of a living organism
GB2521997A (en) 2013-09-06 2015-07-15 Biocompatibles Uk Ltd Radiopaque polymers
WO2016175728A1 (en) * 2015-04-27 2016-11-03 Aydin Kimya Sanayi Ve Ticaret Anonim Sirketi Production method for a pdms-i based antimicrobial solution
WO2016209966A1 (en) 2015-06-22 2016-12-29 Infection Containment Company, LLC Topical antiseptic system
CN110403923B (zh) 2015-09-30 2021-09-21 诺瓦利克有限责任公司 半氟化化合物和其组合物
CN110678207B (zh) * 2017-04-21 2024-08-02 德马利克治疗公司 碘组合物
EP3687496A1 (en) 2017-09-27 2020-08-05 Novaliq GmbH Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
WO2020064549A1 (en) 2018-09-27 2020-04-02 Novaliq Gmbh Lipid barrier repair
KR102404412B1 (ko) 2018-09-27 2022-05-31 노바리크 게엠베하 국소 선스크린 제제
CN112755050B (zh) * 2020-12-31 2022-11-15 佛山市正典生物技术有限公司 一种具有高组分稳定性的不含醇含碘消毒剂及其制备方法
CN114208818B (zh) * 2021-11-09 2022-10-04 佛山市正典生物技术有限公司 包含多元醇醚和/或环醚的含碘消毒剂及制备方法
US20230181801A1 (en) * 2021-12-09 2023-06-15 I2Pure Corp. Molecular iodine-infused polymers, articles, and products, and their preparation and use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081232A (en) * 1960-12-27 1963-03-12 Warner Lambert Pharmaceutical Iodine preparation and method of disinfecting the skin
US4384960A (en) 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
FR2611733B1 (fr) 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2611734B1 (fr) 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polycondensation contenant de l'iode pour le traitement des eaux
FR2611735B1 (fr) 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polyaddition contenant de l'iode pour le traitement de l'eau
FR2634772A1 (fr) 1988-07-29 1990-02-02 Rhone Poulenc Chimie Composition a base d'huile diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2648143B1 (fr) 1989-06-08 1991-09-06 Rhone Poulenc Chimie Composition comprenant un copolymere silicone thermoplastique et un compose de l'iode, utilisable apres sa mise en forme, pour le traitement des eaux
US6024968A (en) * 1991-08-16 2000-02-15 Lincoln Technologies Inc. Intersorption composition and method
DE19837850C1 (de) 1998-08-20 2000-01-05 Wacker Chemie Gmbh Mischungen flüchtiger linearer Siloxane, Verfahren zu ihrer Herstellung sowie diese enthaltenden kosmetischen Formulierungen
JP2006083119A (ja) * 2004-09-17 2006-03-30 Mandom Corp 殺菌消毒剤組成物
WO2006138035A1 (en) * 2005-06-13 2006-12-28 Dow Corning Corporation Vehicle for the delivery of topical lipid soluble pharmaceutical agents
US20070036731A1 (en) * 2005-08-13 2007-02-15 Collegium Pharmaceutical, Inc. Topical Delivery with a Carrier Fluid

Also Published As

Publication number Publication date
BR112013000690A2 (pt) 2016-05-17
HU1000362D0 (en) 2010-10-28
EP2592935A2 (en) 2013-05-22
TW201216859A (en) 2012-05-01
EA022847B1 (ru) 2016-03-31
HK1150373A2 (en) 2011-12-16
UA109144C2 (ru) 2015-07-27
HUP1000362A2 (en) 2012-11-28
UY33502A (es) 2012-01-31
WO2012007776A2 (en) 2012-01-19
GEP20156236B (en) 2015-01-26
WO2012007776A3 (en) 2012-06-07
EA201390090A1 (ru) 2013-05-30

Similar Documents

Publication Publication Date Title
AR082155A1 (es) Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido
UY29086A1 (es) Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos.
CL2015001984A1 (es) (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
BR112014008255A2 (pt) composições antimicrobianas e métodos empregando as mesmas
CR20150523A (es) Uso de 2,3-dihidroimidazo [1,2-c]quinazolinas sustituidas
PE20150668A1 (es) Formulaciones farmaceuticas topicas no acuosas
UY33984A (es) Uso de 2,3-dihidroimidazo [1,2-c] quinazolinas sustituidas
WO2014186742A3 (en) Anhydrous hydrogel composition
CO6720961A2 (es) Imidazopiridazinas sustituidas
BR112015023391A2 (pt) formulações compreendendo conjugado droga-anticorpo anti-egfr
BR112015000520A2 (pt) agente de espessamento estável com lipase
MX339205B (es) Formulaciones de adamts13 liquidas y liofilizadas, estabilizadas.
CL2013000718A1 (es) Un complejo de inclusion que comprende a) una ciclodextrina, b) fulvestrant y c) un portador; su metodo de preparacion; formulacion y forma de dosificacion que comprende al complejo; preparacion que comprende al complejo o a la formulación; y su uso en el tratamiento del cancer y lupus eritematoso sistemico, entre otras enfermedades.
CL2011003065A1 (es) Formulacion vesicular que comprende uno o mas fosfolipidos y uno o mas surfactantes no ionicos, libre de cualquier agente farmaceuticamente activo, util para el tratamiento del dolor asociado con osteoartritis.
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
UY35360A (es) Imidazopiridazinas sustituidas
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
DOP2016000007A (es) Pirazolpiridinas sustituidas
JP2013513660A5 (es)
WO2015003082A3 (en) Volatile organic compound formulations having antimicrobial activity
BR112014014026A2 (pt) análogos de magnolol solubilizados
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.
PE20121537A1 (es) Combinacion de teobromina con un descongestivo
BR112015000647A2 (pt) composições orais líquidas e pediátricas que contêm nepadutant

Legal Events

Date Code Title Description
FB Suspension of granting procedure